Jacek L. Mostwin, M.D., D. Phil. (Oxon), Medical Editor
Dr. Mostwin, a urological surgeon at Johns Hopkins, maintains a busy medical practice focusing on prostate cancer. He has performed more than 2,500 radical prostatectomies over the years. Among his major research interests are urinary continence issues and bladder function. Most of Dr. Mostwin's scientific publications have dealt with lower urinary tract problems.

We have assembled a prestigious medical advisory board comprised of faculty members at Johns Hopkins to provide you with information that can help prevent your quality of life from diminishing even if you do suffer from a prostate disorder.

Alan W. Partin, M.D., Ph.D.
is a renowned surgeon, researcher, and teacher whose work has influenced urological advances. Dr. Partin, Professor and Director of the James Buchanan Brady Urological Institute at Johns Hopkins, has both a basic science and clinical interest in prognosis prediction for men with prostate cancer. He is a dedicated scientist. Over the years, he has focused his scientific attention on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians.
The Partin tables, the diagnostic prostate cancer nomograms that Dr. Partin developed in 1993, now help prostate cancer patients the world over get an accurate prediction of their likelihood of being cured.

The physicians and researchers at the Johns Hopkins Brady Urological Institute aspire to provide the best medical care for patients through world-class medical practice, research and education.

Under the direction of chairman Dr. Alan Partin, the clinical facility is the world leader in treating prostate cancer, benign prostate hyperplasia, erectile dysfunction, incontinence and bladder dysfunction.

The research faculty, under the guidance of Dr. Robert H. Getzenberg, is renowned for breakthrough research in areas ranging from tumor suppressors and gene therapy to cell adhesion molecules and tumor markers.

A Personal Letter from Dr. Mostwin, which reviews critical prostate developments of the past few weeks. Treatment strategies. Early intervention options. New clinical trials. Reports from urological conferences that are helping to improve and prolong men’s lives.

In-Depth Reports give you the latest information about everything from new medications and preventive measures to dietary guidelines and minimally invasive procedures. Informative articles from leading prostate experts. No sensationalism. No hype. No hard-to-decipher medical jargon — just the facts you need to make better-informed health decisions.

Some of The Prostate Bulletin issues also include:

Grand Rounds: readers pose detailed questions about difficult health care decisions — and get detailed answers from top Hopkins urology specialists. The Bulletin helps you recognize early warning signs… communicate more effectively with your physician… understand your options.

RISK-FREE GUARANTEE

Evaluate The Johns Hopkins Prostate Bulletin Fall 2007 on a risk-FREE basis. If you're dissatisfied in any way, contact Customer Service and you'll receive a prompt refund of the entire cost, no questions asked.

>Don't miss out on The Prostate Bulletin's Fall 2007: The Future of Surgical Technology, and The PSA Testing Debate
Order today

The Johns Hopkins Prostate Bulletin Fall 2007:

The Future of Surgical Technology
Prostate Cancer Screening after Age 65: The AUA Debate
Get the latest cutting-edge news on prostate disorders now

For nearly a decade, the specialists at Johns Hopkins' James Buchanan Brady Urological Institute have been bringing you the latest news on the major breakthroughs in treating prostate cancer, BPH and prostatitis in The Johns Hopkins Prostate Bulletin.

In The Prostate Bulletin Fall 2007 issue, Dr. Jacek Mostwin, Medical Editor, begins this information-packed issue with a comprehensive review of the major prostate research findings since the last issue of the Prostate Bulletin.

In his Doctor's letter, you will learn the latest news on:

• Prostate cancer prevention through diet, and what you need to know about lycopene.
• Saw palmetto for an enlarged prostate: any risks, any benefits?
• An overview of all the BPH drugs currently available for treating your enlarged prostate.
• Statin drugs: not just for lower cholesterol, but for prostate cancer protection too?
• What are your options if you suffer from prostate cancer recurrence?
• What to do if you are considering joining a clinical trial.
• Achieving the best outcome with a radical prostatectomy.

In the first in-depth special report in this issue, written by Dr. Dan Stoianovici, you'll get an update on the progress on minimally-invasive prostate cancer surgery, robotic radical prostatectomy, and emerging new technologies, including HIFU, now currently in its Phase II trials with Sonablate.

The second in-depth report in this issus is a transcript of The AUA Debate: Prostate Cancer Screening after Age 65, on PSA testing, its benefits, and wider issues for diagnosing and treating prostate cancer.

In addition to all of the articles above, as soon as you download your copy of the Fall 2007 Prostate Bulletin you'll also be able to start reading through the Grand Rounds section, with the answers to many of your pressing concerns on prostate disorders. The Grand Rounds topics include:

• My PSA has been rising after brachytherapy: what are my options?
• Erectile dysfunction after a radical prostatectomy.
• Penile shrinkage and Peyronie's disease after a radical prostatectomy.
• Do I need a prostate biopsy?
• What you can expect after a radical prostatectomy.
• What should I do if my husband refuses any sort of prostate cancer treatment?
• Best drug choices for BPH?
• Bladder difficulties after radiation.
• Will Kegel exercises before a radical prostatectomy help my recovery and urinary continence?
• How long should I expect to be in the hospital after my radical prostatectomy?
• What is the difference between a retropubic radical prostatectomy and a perineal radical prostatectomy?
• Expectant management versus a radical prostatectomy in the over 70s age group.
• Radiation versus a radical prostatectomy; which offers a better chance of full return of erectile function?
• The role of PIN (prostatic intraepithelial neoplasia) in your prostate biopsy: is it a sign of cancer?
• What to do when a positive margin remains after a robotic radical prostatectomy.

Each issue of The Prostate Bulletin brings you the latest information on prostate disorders in clear, easy to understand language, saving you time, money and effort in seeking out the best information available on prostate health.

Johns Hopkins specialists act as your filter, sorting through all the research, clinical trials, and major medical journals, to explain the complicated medical data and science behind the headlines in layman's language, so you can act on the information to make the best-informed decisions about your prostate health.

Those who already subscribe to The Johns Hopkins Prostate Bulletin will have already received this Fall 2007 issue, but countless more subscribers and visitors to the website missed out on this crucial health information once all the printed issues sold out.

Due to the demand for this issue on The Future of Surgical Technology and The PSA Testing Debate thanks to this special offer, you can now get the instant PDF digital download edition at the special discounted offer of $24.95.

That's right, you'll get 48 pages of this invaluable prostate information direct from Hopkins' expert panel of specialists at Johns Hopkins, ranked America's #1 Medical Center and #1 Urology Center for 19 consecutive years.

SAVE 40%

This wealth of information is available to your right now as an instant PDF digital download, and at 40% off the list price.

Normally, a subscription to the quarterly Johns Hopkins Prostate Bulletin is priced at $199 per year for 4 issues, sent out in the post via Priority Mail. That's $49.95 per issue.

But for a limited time only, you can get this digital PDF download edition of Fall 2007: The Future of Surgical Technology from The Johns Hopkins Prostate Bulletin for $49.95 only $24.95.

This is news you can use as you work with your doctor to stay as informed and proactive as possible about your prostate health. You will discover essential information on prostate cancer, its prevention, treatment, and cure. What emerging medications and technologies are of greatest interest for eradicating prostate cancer. The latest news on laparoscopic and robotic radical prostatectomy. The newest diagnostic tests. And whether you are eligible for any new or ongoing clinical trials.

This kind of cutting-edge information published in The Prostate Bulletin is usually inaccessible to the average reader, hidden in obscure medical journals, garbled on the internet, or covered incompletely in minuscule articles in the back of the daily newspaper. Or worse still, sensationalized on the 6 o'clock news.

This kind of breakthrough research, these study findings, and clinical trials are so new in some instances, that even your busy doctor might not have ready access to this up-to-the-minute news in this highly specialized field.

As the nation's #1 Best Hospital and #1 Urological Center for the past 19 years, Johns Hopkins' James Buchanan Brady Urological Institute is in a unique position to evaluate and disseminate the very latest information concerning advances in prostate treatment, reporting on their own research, and surveying the most promising findings from studies all over the globe. Every issue of The Prostate Bulletin provides 48 pages of detailed information direct from the doctors and researchers on the front line in the battle against prostate cancer.

Once you download The Prostate Bulletin, Fall 2007 as a PDF file, you can start reading it immediately. You'll be able to discuss what you learn with your doctor and loved ones, and apply all you learn at once, to help you make the most informed decisions about your health to prevent or treat prostate cancer.

The Fall 2007 issue, containing The Future of Surgical Technology and The PSA Testing Debate, will help you take control of your health, secure in the knowledge that your information is coming from the most trusted name in the world in successful prostate cancer treatment.

And as always, your purchase is completely RISK-FREE. The Prostate Bulletin Fall 2007 issue comes with a full 100% money-back guarantee. If you're not satisfied with your issue, simply contact Customer Service within 30 days for a full refund.

Don't hesitate. Take advantage of this RISK-FREE offer now. Order now, and take charge of your prostate health today.

ORDER NOW, DOWNLOAD IN MINUTES

---

You can use your Mastercard and Visa credit/debit cards at this site.

This is a secure shopping site.
But if your prefer to place your order over the phone, or have any further questions, please contact:
Customer Service:
Inside US and Canada: 1-212-792-5417
Hours: M to F - 9AM to 9PM EST/EDT
Sat & Sun - 9AM TO 6PM EST/EDT
Email: customerservice@johnshopkinshealthalerts.com